BCM
NRXPW

Bluefin Capital Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Bluefin Capital Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-101,600
Closed -$18K – 432
2019
Q1 		$18K Buy
+101,600
New +$25.6K ﹤0.01% 342

Other funds holding NRXPW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
VAS
VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Bluefin Capital Management's NRXPW Position: Q2 2019 in Review

Bluefin Capital Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q2 2019, closing a stake of 101,600 shares — an estimated $18K sold.

Bluefin Capital Management first reported a position in NRXPW in Q1 2019 and held it in 1 quarter. The position peaked at $18K in Q1 2019. 19 funds tracked by Wall St. Rank hold NRXPW as of Q2 2019.

  • Bluefin Capital Management reported no remaining NRX Pharmaceuticals Warrant position as of Q2 2019 after selling out during the quarter.
  • Bluefin Capital Management sold 101,600 NRX Pharmaceuticals Warrant shares in Q2 2019, an estimated $18K.
  • Bluefin Capital Management first reported a position in NRX Pharmaceuticals Warrant in Q1 2019 and held it in 1 quarter.
  • Bluefin Capital Management's NRX Pharmaceuticals Warrant position peaked at $18K in Q1 2019.
  • 19 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q2 2019.

Based on Bluefin Capital Management's 13F filing for Q2 2019, filed 15 Aug 2019.